JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

JNJ

225.85

-0.11%↓

ABT

91.74

-1.11%↓

MDT

83.27

+0.9%↑

120.69

-1.07%↓

VEEV

162.96

-2.86%↓

Начало・Списък с акции・Vaxart Inc

Vaxart Inc

Затворен

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

Ключови измерители
By Trading Economics
Приходи	63M 55M
Продажби	32M 104M
P/E Средно за сектора	10.856 60.328
EPS	0.24
Марж на печалбата	52.807
Служители	65
EBITDA	63M 58M

Дивиденти
By Dow Jones
Следващи печалби	12.05.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-8.2M 184M
Предишно отваряне	0
Предишно затваряне	0

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

0.4007 / 0.4252 Подкрепа & съпротива

Vaxart Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

23.04.2026 г., 00:00 ч. UTC

Значими събития в новините

Australian Flash PMI Bounce in April Conceals Deeper Worries

22.04.2026 г., 23:33 ч. UTC

Печалби

SK Hynix Posts Record Quarterly Results Amid AI Boom

22.04.2026 г., 22:40 ч. UTC

Печалби

Correction to ServiceNow Posts 22% 1Q Revenue Growth Article

22.04.2026 г., 22:10 ч. UTC

Придобивния, сливания и поглъщания

ServiceNow Says $4 Billion Term Loan Credit Deal Will Help Finance Armis Security Deal

22.04.2026 г., 21:11 ч. UTC

Печалби

ServiceNow Posts 22% 1Q Revenue Growth, But Says Armis Deal Will Weigh on Margins

22.04.2026 г., 21:01 ч. UTC

Печалби

IBM Posts Higher 1Q Sales, Buoyed by AI -- Update

22.04.2026 г., 23:46 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

22.04.2026 г., 23:46 ч. UTC

Пазарно говорене

Nikkei May Remain Rangebound; Middle East Conflict in Focus -- Market Talk

22.04.2026 г., 23:34 ч. UTC

Пазарно говорене

Значими събития в новините

Gold Falls as U.S.-Iran Cease-Fire Keeps Inflation Concerns High -- Market Talk

22.04.2026 г., 23:16 ч. UTC

Печалби

SK Hynix: Quarterly Revenue, Profits at All-Time High in 1Q

22.04.2026 г., 23:15 ч. UTC

Печалби

SK Hynix: Operating Profit Margin Reached Record 72% in 1Q

22.04.2026 г., 22:54 ч. UTC

Печалби

SK Hynix 1Q Net Profit Beat FactSet-Compiled Consensus

22.04.2026 г., 22:54 ч. UTC

Печалби

SK Hynix 1Q Net KRW40.346T Vs. Net KRW8.108T >000660.SE

22.04.2026 г., 22:52 ч. UTC

Печалби

SK Hynix 1Q Oper Pft KRW37.610T Vs. Pft KRW7.441T >000660.SE

22.04.2026 г., 22:51 ч. UTC

Печалби

SK Hynix 1Q Rev KRW52.576T Vs. KRW17.639T >000660.SE

22.04.2026 г., 22:31 ч. UTC

Печалби

Sandfire CEO: Delivery Risk, Input Cost Pressure Could Rise Quickly If Situation Deteriorates

22.04.2026 г., 22:31 ч. UTC

Печалби

Sandfire CEO: First, Second Order Impacts of Middle East Conflict Remain Hard to Predict

22.04.2026 г., 22:30 ч. UTC

Печалби

Sandfire CEO: Middle East Conflict Creates Significant Risk in Global Supply Chains

22.04.2026 г., 22:30 ч. UTC

Печалби

Sandfire: FY26 Underlying Operating Unit Costs Expected to 'Materially Aligned' With Guidance

22.04.2026 г., 22:29 ч. UTC

Печалби

Sandfire Resources 3Q Unaudited Underlying Ebitda $220 Million

22.04.2026 г., 22:28 ч. UTC

Печалби

Sandfire Resources 3Q Unaudited Sales Revenue $408 Million

22.04.2026 г., 22:28 ч. UTC

Печалби

Sandfire Resources 3Q Motheo Underlying Operating Unit Cost $44/Ton Ore Processed

22.04.2026 г., 22:27 ч. UTC

Печалби

Sandfire Resources 3Q Matsa Underlying Operating Unit Cost $95/Ton Ore Processed

22.04.2026 г., 22:06 ч. UTC

Пазарно говорене

Печалби

Tesla Paid Robotaxi Miles Nearly Doubled Quarter-Over-Quarter -- Market Talk

22.04.2026 г., 21:55 ч. UTC

Придобивния, сливания и поглъщания

ServiceNow Says $4B Term Loan Credit Deal Will Help Finance Armis Security Deal

22.04.2026 г., 21:47 ч. UTC

Печалби

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22.04.2026 г., 21:37 ч. UTC

Печалби

Texas Instruments Reports Solid Earnings. The Stock Is Up. -- Barrons.com

22.04.2026 г., 21:34 ч. UTC

Печалби

Tesla Surprises Wall Street With Better Profits, $1.4 Billion in Free Cash Flow -- 3rd Update

22.04.2026 г., 21:29 ч. UTC

Печалби

Lam Research Stock Jumps on Strong Earnings -- Barrons.com

22.04.2026 г., 21:20 ч. UTC

Пазарно говорене

Печалби

Tesla Expands Manufacturing to Chips -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Vaxart Inc Прогноза

Консенсусна оценка

By TipRanks

0 ratings

Купи

Задържане

Продай

Според 0 анализатори, дали борсови рейтинги на Vaxart Inc през последните 3 месеца.

Техническа оценка

By Trading Central

0.4007 / 0.4252Подкрепа & съпротива

Recent bearish events outweigh bullish events.

There is one bearish event.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Vaxart Inc

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influenza vaccine, which is in Phase 2 clinical trial, to treat H1 influenza infection; and human papillomavirus therapeutic vaccine, which is in preclinical stage, that targets HPV-16 and HPV-18 for cervical cancers and precancerous cervical lesions. It has a license agreement with Altesa Biosciences, Inc. to develop and commercialize Vapendavir, a capsid-binding broad-spectrum antiviral. Vaxart, Inc. is headquartered in South San Francisco, California.